Ceftazidime-avibactam is a combination of a third-generation cephalosporin and a novel non-beta-lactam beta-lactamase inhibitor. This combination was recently recommended for the treatment of complicated urinary tract infections, including acute pyelonephritis, in adults with limited or no alternative treatment options. The current review is aimed to determine activity, efficacy and safety of ceftazidime-avibactam in the treatment of patients with complicated urinary tract infections.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2217/fmb-2016-0213 | DOI Listing |
Publication Analysis
Top Keywords
complicated urinary
12
urinary tract
12
tract infections
12
treatment complicated
8
ceftazidime-avibactam novel
4
novel antimicrobial
4
antimicrobial combination
4
treatment
4
combination treatment
4
infections ceftazidime-avibactam
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!